The Joint Commission is making available pre-publication versions of the 2010 National Patient Safety Goals; these goals do not include scoring information, service applicability, or final editorial changes that may be made. Final versions of the NPSGs will be posted on the Joint Commission Web site in late September.
The Joint Commission has revised the 2010 NPSGs and some changes are effective immediately. The changes were made partly in response to concerns from the field about the resources needed to comply with NPSGs that have become more specific and detailed over time. The revisions include clarifying and streamlining certain EPs, as well as deleting some requirements and moving others to the standards. For the remainder of 2009, during the onsite survey, surveyors will not evaluate compliance with the requirements that have been deleted. Other changes will be effective Jan. 1, 2010. Read the Sept. 9, 2009 issue of Joint Commission Online for more information about these changes.
The Universal Protocol has also been revised and some changes are effective immediately. For the remainder of 2009, during the onsite survey, surveyors will not evaluate compliance with the following requirements that were eliminated or substantially modified: UP.01.01.01 EPs 1, 2; UP.01.02.01 EPs 1, 2, 3, 7; UP.01.03.01 EPs 1, 5, 6. Other changes will be effective January 1, 2010. (These EPs are the 2009 NPSG numbers; the EPs for the 2010 versions were renumbered because some EPs were deleted or moved. The 2009 numbers reflected here are in the 2009 print manual and the current 2009 E-dition.)
Based on the recent decision to limit Disease-Specific Care certification to programs in Joint Commission accredited organizations only, the parent organizations of DSC programs will be responsible for making sure that the DSC program meets applicable NPSGs. The DSC program will no longer have its own set of NPSGs.
While no new NPSGs have been developed for 2010, on Jan. 1, 2010, organizations will be expected to have fully implemented the requirements related to healthcare-associated infections (which were established with the 2009 NPSGs).
For the pre-publication versions of the NPSGs, CLICK HERE.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.